FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors

被引:0
|
作者
Higashi, T [1 ]
Tamaki, N
Torizuka, T
Nakamoto, Y
Sakahara, H
Kimura, T
Honda, T
Inokuma, T
Katsushima, S
Ohshio, G
Imamura, M
Konishi, J
机构
[1] Kyoto Univ, Fac Med, Dept Nucl Med, Sakyo Ku, Kyoto 60601, Japan
[2] Kyoto Univ, Fac Med, Dept Surg 1, Kyoto 606, Japan
[3] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan
关键词
pancreatic tumor; GLUT-1; expression; fluorodeoxyglucose PET; immunohistochemistry; cellularity;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We previously reported that grading of GLUT-1 glucose transporter expression was related closely to FDG accumulation in FDG PET in human cancers. But in this strong GLUT-1 expression group, there was an enormous range of standardized uptake values (SUVs) within them. Methods: To evaluate other factors determining the FDG PET uptake, FDG PET was performed in 36 preoperative patients (mean age 62.0 yr) suspected of having pancreatic tumors, including 33 malignant and 3 benign neoplastic tumors. FDG uptake at 50 min after injection of 185 MBq F-18-FDG with > 5 hr fasting condition was semiquantitatively analyzed as SUVs, The GLUT-1 expression was studied by immunohistochemistry of paraffin sections from these tumors after the operation using the antiGLUT-1 antibody. The number of tumor cells within a 5- x 5-mm square was counted manually using x200 magnification photographs and was graded immunohistochemically as strong, weak or negative. Results: In all 36 cases there were 3 cases of GLUT-1 negative, 8 of GLUT-1 weak positive and 25 of GLUT-1 strong positive. In all cases, the total number of tumor cells had no significant value for SUVs, Among 33 GLUT-1 positive cases, the number of GLUT-1 positive tumor cells correlated significantly with SUVs (p < 0.01). Only in 25 strong grade cases, the number of GLUT-I strong positive tumor cells had a more significant Value for SUVs (p < 0.005). Computational multivariate analysis using multiple regression for SUVs was performed evaluating the five variables as follows: tumor size, GLUT-1 immunohistochemical grading, number of total tumor cells, number of total GLUT-1 positive tumor cells and number of GLUT-1 strong positive cells. This analysis revealed that only the variable, the number of GLUT-1 strong positive cells, had a significant regression coefficient for SUVs (standard regression coefficient = 0.855, p < 0.0001). Conclusion: These data indicate that GLUT-1 expression plays an essential role in higher FDG accumulation in pancreatic tumor FDG PET, and the cellularity has a significant influence on SUVs only in the condition of GLUT-1 strong positive expression.
引用
收藏
页码:1727 / 1735
页数:9
相关论文
共 50 条
  • [1] Correlation of GLUT-1 glucose transporter with FDG uptake in human pancreatic tumors.
    Higashi, T
    Torizuka, T
    Inokuma, T
    Nakamoto, Y
    Honda, T
    Kimura, T
    Magata, Y
    Yonekura, Y
    Konishi, J
    Tamaki, N
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1111 - 1111
  • [2] Multivariate analysis of FDG uptake in human pancreatic tumors: Expression of GLUT-1 glucose transporter and tumor cell cellularity.
    Higashi, T
    Tamaki, N
    Torizuka, T
    Nakamoto, Y
    Sakahara, H
    Kimura, T
    Honda, T
    Inokuma, T
    Ohshio, G
    Imamura, M
    Konishi, J
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 250P - 250P
  • [3] Multivariate analysis of FDG uptake in human pancreatic cancers: Prognosis, GLUT-1 glucose transporter and tumor cellularity.
    Higashi, T
    Saga, T
    Nakamoto, Y
    Ishimori, T
    Mamede, MH
    Doi, R
    Hosotani, R
    Imamura, M
    Konishi, J
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 281P - 281P
  • [4] Overexpression of GLUT-1 glucose transporter in human malignant pancreatic tumors. Immunohistochemical study of GLUT-1, 2, 3, 4, and 5 glucose transporters
    Higashi, T
    Honda, T
    Kimura, T
    Magata, Y
    Konishi, J
    Ohshio, G
    Hosotani, R
    Imamura, M
    Tamaki, N
    GASTROENTEROLOGY, 1996, 110 (04) : A528 - A528
  • [5] CONCORDANTLY INCREASED GLUCOSE TRANSPORTER-1 (GLUT-1) GENE-EXPRESSION AND FDG-UPTAKE IN HUMAN PANCREATIC-CARCINOMA
    KORNRUMPF, D
    BUCHLER, M
    LANGHANS, J
    BEGER, HG
    RESKE, SN
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P223 - P223
  • [6] FDG uptake of bronchioloalveolar lung carcinoma: Correlation with expression of GLUT-1 glucose transporter.
    Higashi, K
    Ueda, Y
    Wang, X
    Xu, L
    Seki, H
    Ayabe, K
    Arisaka, Y
    Oguchi, M
    Yamamoto, I
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 22P - 22P
  • [7] INCREASED FDG-UPTAKE IN HUMAN PANCREATIC-CARCINOMA IS ASSOCIATED TO OVER-EXPRESSION OF GLUCOSE-TRANSPORTER 1 GENE (GLUT-1)
    SCHONBERGER, JA
    STOLLFUSS, JC
    BEGER, HG
    RESKE, SN
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P117 - P117
  • [8] Glucose transporter 1 (GLUT-1) in human skeletal muscle
    Schroeder, HD
    Gaster, M
    Handberg, A
    Beck-Nielsen, H
    DIABETES, 1999, 48 : A290 - A291
  • [9] Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary
    Cantuaria, G
    Magalhaes, A
    Penalver, M
    Angioli, R
    Braunschweiger, P
    Gomez-Marin, O
    Kanhoush, R
    Gomez-Fernandez, C
    Nadji, M
    GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 33 - 37
  • [10] Glucose transporter type 1 (GLUT-1) deficiency
    Bzduch, V
    Sykora, P.
    Behulova, D.
    Kolnikova, M.
    Klcova, V
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (05): : 245 - 245